DataKnowledgeCloudtrainingcoordination

Pulmonary arterial hypertension (Disease Or Phenotype)

Omim:MTHU037923

Nci:C157552

Msh:D000081029

Mondo:MONDO:15924

Medcin:MEDCIN:397718

Mdr:MDR:10064911

Id:5f6f35f5-618f-505e-a034-40506f0a3c73

Icpc2icd10eng:MTHU036495

Efo:EFO:1361

Results found

Linked to

	Label	Description
	Selexipag indication Pulmonary arterial hypertension Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	MRE-269 indication Pulmonary arterial hypertension Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	terguride indication Pulmonary arterial hypertension Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	PGI<sub>2</sub> indication Pulmonary arterial hypertension Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Iloprost indication Pulmonary arterial hypertension Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]-N'-propylsulfamide indication Pulmonary arterial hypertension Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Bosentan indication Pulmonary arterial hypertension Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	5-[2-Ethoxy-5-(4-methyl-piperazine-1-sulfonyl)-phenyl]-1-methyl-3-propyl-1,6-dihydro-pyrazolo[4,3-d]pyrimidin-7-one indication Pulmonary arterial hypertension Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	2-[2-(6-Methyl-benzo[1,3]dioxol-5-yl)-acetyl]-thiophene-3-sulfonic acid (4-chloro-3-methyl-isoxazol-5-yl)-amide indication Pulmonary arterial hypertension Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Ambrisentan indication Pulmonary arterial hypertension Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Selexipag indication Pulmonary arterial hypertension

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

MRE-269 indication Pulmonary arterial hypertension

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

terguride indication Pulmonary arterial hypertension

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

PGI<sub>2</sub> indication Pulmonary arterial hypertension

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Iloprost indication Pulmonary arterial hypertension

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]-N'-propylsulfamide indication Pulmonary arterial hypertension

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Bosentan indication Pulmonary arterial hypertension

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

5-[2-Ethoxy-5-(4-methyl-piperazine-1-sulfonyl)-phenyl]-1-methyl-3-propyl-1,6-dihydro-pyrazolo[4,3-d]pyrimidin-7-one indication Pulmonary arterial hypertension

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

2-[2-(6-Methyl-benzo[1,3]dioxol-5-yl)-acetyl]-thiophene-3-sulfonic acid (4-chloro-3-methyl-isoxazol-5-yl)-amide indication Pulmonary arterial hypertension

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Ambrisentan indication Pulmonary arterial hypertension

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.